Cargando…
Canakinumab and cardiovascular outcomes: results of the CANTOS trial
IL-1 cytokines are mainly responsible for controlling a series of pro-inflammatory reactions induced in response to pathogen mediated tissue injury. Among the IL-1 cytokine family, IL-1 β results in upregulation of genes responsible for boosting immune system reactivity and inflammatory response. Wi...
Autores principales: | Shah, Syed Raza, Abbasi, Zainab, Fatima, Mazia, Ochani, Rohan Kumar, Shahnawaz, Waqas, Asim Khan, Muhammad, Shah, Syed Arbab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804673/ https://www.ncbi.nlm.nih.gov/pubmed/29441161 http://dx.doi.org/10.1080/20009666.2018.1428023 |
Ejemplares similares
-
Atrial fibrillation and heart failure- results of the CASTLE-AF trial
por: Shah, Syed Raza, et al.
Publicado: (2018) -
Canagliflozin and Cardiovascular disease- results of the CANVAS trial
por: Shah, Syed Raza, et al.
Publicado: (2018) -
Bioresorbable vascular scaffold versus metallic stent in percutaneous coronary intervention: results of the AIDA trial
por: Shah, Syed Raza, et al.
Publicado: (2017) -
Using left ventricular assist devices in advanced heart failure patients
por: Shah, Syed Raza, et al.
Publicado: (2018) -
Evolocumab to reduce cardiovascular events: results of the (FOURIER) multinational trial
por: Shah, Syed Raza, et al.
Publicado: (2017)